Cibc World Market Inc. Eli Lilly & CO Transaction History

Cibc World Market Inc.

$48 Billion
Q3 2024

A detailed history of Cibc World Market Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Cibc World Market Inc. holds 179,592 shares of LLY stock, worth $143 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

179,592

Previous 163,286 9.99%

Holding current value

$143 Million

Previous $148 Million 7.62%

% of portfolio

0.33%

Previous 0.34%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $12.6 Million - $15.7 Million	16,306 Added 9.99%	179,592 $159 Million
Q2 2024 Aug 07, 2024	BUY	$724.87 - $909.04 $12.8 Million - $16 Million	17,592 Added 12.07%	163,286 $148 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $10.7 Million - $14.3 Million	18,070 Added 14.16%	145,694 $113 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $905,427 - $1.07 Million	1,724 Added 1.37%	127,624 $74.4 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $6.56 Million - $9.05 Million	15,097 Added 13.63%	125,900 $67.6 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $5.92 Million - $7.91 Million	16,873 Added 17.96%	110,803 $52 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $12.2 Million - $14.4 Million	-39,431 Reduced 29.57%	93,930 $32.3 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $209,329 - $243,910	-651 Reduced 0.49%	133,361 $48.8 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $1.36 Million - $1.55 Million	-4,601 Reduced 3.32%	134,012 $43.3 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $3.95 Million - $4.63 Million	14,157 Added 11.38%	138,613 $44.9 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $530,868 - $659,734	2,262 Added 1.85%	124,456 $35.6 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $11 Million - $13.7 Million	49,137 Added 67.26%	122,194 $33.8 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $1.8 Million - $2.22 Million	8,128 Added 12.52%	73,057 $16.9 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $194,632 - $251,756	-1,078 Reduced 1.63%	64,929 $14.9 Million
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $481,950 - $623,907	-2,933 Reduced 4.25%	66,007 $12.3 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $84,929 - $112,382	-651 Reduced 0.94%	68,940 $11.6 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $2.11 Million - $2.44 Million	-14,415 Reduced 17.16%	69,591 $10.3 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $3.12 Million - $3.76 Million	22,903 Added 37.48%	84,006 $13.8 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $3.08 Million - $3.81 Million	-25,869 Reduced 29.74%	61,103 $8.48 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $326,319 - $404,176	3,052 Added 3.64%	86,972 $11.4 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $4.86 Million - $5.29 Million	45,522 Added 118.55%	83,920 $9.39 Million
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $25.8 Million - $30.1 Million	-232,437 Reduced 85.82%	38,398 $4.25 Million
Q1 2019 May 09, 2019	BUY	$111.31 - $131.02 $17.7 Million - $20.9 Million	159,252 Added 142.72%	270,835 $35.1 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $2.94 Million - $3.29 Million	27,744 Added 33.09%	111,583 $12.9 Million
Q3 2018 Nov 09, 2018	SELL	$85.86 - $107.31 $7.34 Million - $9.18 Million	-85,517 Reduced 50.5%	83,839 $9 Million
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $5.74 Million - $6.58 Million	-75,762 Reduced 30.91%	169,356 $14.5 Million
Q1 2018 May 18, 2018	BUY	$74.21 - $87.6 $8.73 Million - $10.3 Million	117,577 Added 92.19%	245,118 $19 Million
Q4 2017 Feb 01, 2018	BUY	$81.94 - $87.89 $694,605 - $745,043	8,477 Added 7.12%	127,541 $10.8 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $9.18 Million - $10.2 Million	119,064	119,064 $10.2 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Account

Cibc World Market Inc. Eli Lilly & CO Transaction History